Tag: Kevin Church
All About Alzheimer’s Clinical Trials, Part 2
Kevin Church, Chief Science Officer of Athira Pharma, provides an overview of clinical trials, how to find clinical trial locations, and what sorts of things the doctors are looking for in a participant.
All About Alzheimer’s Clinical Trials, Part 1
Kevin Church, Chief Science Officer of Athira Pharma, provides an overview of what happens in a trial, how long they last, and the different kinds of clinical trials.
Reversing Brain Cell Damage from Alzheimer’s
Kevin Church, Chief Science Officer of Athira Pharma, joins Suzanne to talk about what happens to the brain when someone has Alzheimer's, and how Athira's clinical trial aims to reverse damage done to brain cells by Alzheimer's.
Pandemic’s Impact for Those with Dementia
Kevin Church, Chief Science Officer of Athira Pharma, joins Suzanne to talk about the pandemic's effect on dementia patients, as well as clinical trials developing treatments for Alzheimer's.